Vistin Pharma ASA (FRA:VP4)

Revenue by Product

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals	435.39M
Pharmaceuticals Growth	51.35%

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Europe	338.87M
Europe Growth	72.91%
Africa	65.70M
Africa Growth	75.29%
Asia	29.32M
Asia Growth	48.11%
North and South America	1.51M
North and South America Growth	-95.63%